Spirometry is the most common type of test for examining lung function. It measures the volume and speed of air breathed in and out by the lungs. The spirometer is an essential tool in assessing conditions like asthma, cystic fibrosis, Chronic Obstructive Pulmonary Disorder (COPD) and pulmonary fibrosis. A spirogram can differentiate between two types of abnormal breathing patterns, restrictive and obstructive.
A person with a restrictive lung disorder (RLD) has difficulty expanding the lungs when drawing in breath. This causes a decrease in lung volume and forces the lungs to work harder. Both oxygenation and ventilation are negatively affected. Pulmonary fibrosis, or scarring of the lungs, falls under the umbrella of RLD. Here, the normal tissue of the lung is dotted with lesions of scar tissue, creating a honeycomb-like appearance. Pulmonary fibrosis is badly understood, normally gets worse with time and is frequently fatal. Fortunately, it is a rare condition.
Other diseases that fall under the definition of RLD include scoliosis, neuromuscular conditions such as amyotrophic lateral sclerosis (ALS), muscular dystrophy (MD), obesity and sarcoidosis. The common symptom that alerts people to the need to see a doctor is always shortness of breath. Sarcoidosis is an autoimmune condition in which the lungs become peppered with inflamed tissue referred to as granulomas. These mostly involve the lungs or the skin. Individuals may develop symptoms spontaneously and recover after a few months, maybe years. Other people never notice the condition and learn about it only after investigations for another condition.
Obstructive lung disorders (OLD) are diagnosed by the presence of obstructed and inflamed airways. Airflow is obstructed and the patient experiences difficulty breathing out. OLDs are are responsible for frequent trips to the hospital. Diseases which fall into the category of obstructive lung disorders include asthma, COPD and bronchitis. One thing these individuals have in common is inability to expire 70% of breath within a one-second time interval.
One of the most common respiratory ailments, asthma most often features wheezing, coughing and breathlessness. Less commonly, patients experience fatigue, rapid breathing and appear to sigh frequently. Occasionally, asthma may be life-threatening.
Cystic fibrosis affects the lungs, liver, intestine and pancreas. Shortness of breath is the most serious symptom of cystic fibrosis. Improvements in diagnosis and treatment have extended the life span for people with CF. In 1959, the median survival age was 6 months. In the United States, it had increased to 37.5 years by 2008. In Canada, the median age at survival grew from 24 to 47.7 between 1982 and 2007. Patients are not so lucky in Russia, where lung transplants are not available and basic medical treatment is expensive. Here, the median age of survival is only 25 years.
The term COPD covers conditions like emphysema and chronic bronchitis. In emphysema, the delicate tissues lining the lungs become irreversibly damaged, most commonly from exposure to cigarette smoke. This limits the person's ability to exhale. While there is no cure for emphysema, smoking cessation will reduce disease progression.
Spirometry is an essential screening tool for distinguishing between obstructive and restrictive lung diseases. Obstructive conditions include asthma, COPD and bronchitis. Both chronic bronchitis and emphysema contribute to chronic obstructive pulmonary disease. Restrictive lung diseases include pulmonary fibrosis, sarcoidosis, obesity hyperventilation syndrome, sarcoidosis, muscular dystrophy and amyotrophic lateral sclerosis (ALS).
A person with a restrictive lung disorder (RLD) has difficulty expanding the lungs when drawing in breath. This causes a decrease in lung volume and forces the lungs to work harder. Both oxygenation and ventilation are negatively affected. Pulmonary fibrosis, or scarring of the lungs, falls under the umbrella of RLD. Here, the normal tissue of the lung is dotted with lesions of scar tissue, creating a honeycomb-like appearance. Pulmonary fibrosis is badly understood, normally gets worse with time and is frequently fatal. Fortunately, it is a rare condition.
Other diseases that fall under the definition of RLD include scoliosis, neuromuscular conditions such as amyotrophic lateral sclerosis (ALS), muscular dystrophy (MD), obesity and sarcoidosis. The common symptom that alerts people to the need to see a doctor is always shortness of breath. Sarcoidosis is an autoimmune condition in which the lungs become peppered with inflamed tissue referred to as granulomas. These mostly involve the lungs or the skin. Individuals may develop symptoms spontaneously and recover after a few months, maybe years. Other people never notice the condition and learn about it only after investigations for another condition.
Obstructive lung disorders (OLD) are diagnosed by the presence of obstructed and inflamed airways. Airflow is obstructed and the patient experiences difficulty breathing out. OLDs are are responsible for frequent trips to the hospital. Diseases which fall into the category of obstructive lung disorders include asthma, COPD and bronchitis. One thing these individuals have in common is inability to expire 70% of breath within a one-second time interval.
One of the most common respiratory ailments, asthma most often features wheezing, coughing and breathlessness. Less commonly, patients experience fatigue, rapid breathing and appear to sigh frequently. Occasionally, asthma may be life-threatening.
Cystic fibrosis affects the lungs, liver, intestine and pancreas. Shortness of breath is the most serious symptom of cystic fibrosis. Improvements in diagnosis and treatment have extended the life span for people with CF. In 1959, the median survival age was 6 months. In the United States, it had increased to 37.5 years by 2008. In Canada, the median age at survival grew from 24 to 47.7 between 1982 and 2007. Patients are not so lucky in Russia, where lung transplants are not available and basic medical treatment is expensive. Here, the median age of survival is only 25 years.
The term COPD covers conditions like emphysema and chronic bronchitis. In emphysema, the delicate tissues lining the lungs become irreversibly damaged, most commonly from exposure to cigarette smoke. This limits the person's ability to exhale. While there is no cure for emphysema, smoking cessation will reduce disease progression.
Spirometry is an essential screening tool for distinguishing between obstructive and restrictive lung diseases. Obstructive conditions include asthma, COPD and bronchitis. Both chronic bronchitis and emphysema contribute to chronic obstructive pulmonary disease. Restrictive lung diseases include pulmonary fibrosis, sarcoidosis, obesity hyperventilation syndrome, sarcoidosis, muscular dystrophy and amyotrophic lateral sclerosis (ALS).
About the Author:
If you are looking for information about a top quality spirometer, visit our web pages online today. You can see details at http://www.henanmedical.com now.
No comments:
Post a Comment